| Cox Family Pharmacy | |
| 1212 Garfield Ave, Ste 102, Parkersburg, West Virginia 26101 | |
| (304) 865-7600 |
| Name | Cox Family Pharmacy |
|---|---|
| Organization Name | Cox Family Pharmacy Inc |
| Location | 1212 Garfield Ave, Ste 102, Parkersburg, West Virginia 26101 |
| Type | Pharmacy |
| Phone | (304) 865-7600 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Behavioral Intervention Research in Hospice and Palliative Care: Building an Evidence Base sets forth research considerations and guidelines to build evidence-based interventions to improve end-of-life care.
Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.
Hospital patients in New York are the latest in the nation to gain legal protection against unexpected bills from doctors who won't accept their insurance.
Retrophin, Inc. today announced that it has signed an agreement with Novartis Pharma AG for an exclusive U.S. license for Syntocinon Nasal Spray, the intranasal formulation of a synthetic version of the naturally occurring peptide hormone oxytocin, for an upfront payment of $5.0 million plus milestone payments and royalties.
Small cell lung cancer (SCLC) cells are missing a surface protein that triggers an immune response, allowing them to hide from one of the body's key cancer defenses, a new study led by UT Southwestern researchers suggests.
› Verified 1 days ago
| NPI Number | 1538170030 |
| Organization Name | COX FAMILY PHARMACY INC |
| Doing Business As | COX FAMILY PHARMACY |
| Type | Pharmacy |
| Address | 1212 Garfield Ave, Ste 102, Parkersburg, WV 26101 |
| Phone Number | 304-865-7600 |
News Archive
Behavioral Intervention Research in Hospice and Palliative Care: Building an Evidence Base sets forth research considerations and guidelines to build evidence-based interventions to improve end-of-life care.
Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.
Hospital patients in New York are the latest in the nation to gain legal protection against unexpected bills from doctors who won't accept their insurance.
Retrophin, Inc. today announced that it has signed an agreement with Novartis Pharma AG for an exclusive U.S. license for Syntocinon Nasal Spray, the intranasal formulation of a synthetic version of the naturally occurring peptide hormone oxytocin, for an upfront payment of $5.0 million plus milestone payments and royalties.
Small cell lung cancer (SCLC) cells are missing a surface protein that triggers an immune response, allowing them to hide from one of the body's key cancer defenses, a new study led by UT Southwestern researchers suggests.
› Verified 1 days ago
News Archive
Behavioral Intervention Research in Hospice and Palliative Care: Building an Evidence Base sets forth research considerations and guidelines to build evidence-based interventions to improve end-of-life care.
Researchers at Vanderbilt University Medical Center, in collaboration with Seaside Therapeutics in Cambridge, Mass., have achieved a milestone in the development of a potential new treatment for fragile X syndrome, the most common genetic cause of autism.
Hospital patients in New York are the latest in the nation to gain legal protection against unexpected bills from doctors who won't accept their insurance.
Retrophin, Inc. today announced that it has signed an agreement with Novartis Pharma AG for an exclusive U.S. license for Syntocinon Nasal Spray, the intranasal formulation of a synthetic version of the naturally occurring peptide hormone oxytocin, for an upfront payment of $5.0 million plus milestone payments and royalties.
Small cell lung cancer (SCLC) cells are missing a surface protein that triggers an immune response, allowing them to hide from one of the body's key cancer defenses, a new study led by UT Southwestern researchers suggests.
› Verified 1 days ago
Andy Boyd's Inhome Medical Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2832 Pike St, Parkersburg, West Virginia 26101 Phone: (304) 422-4545 | |
Cvs Pharmacy # 06274 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1605 7th Street, Parkersburg, West Virginia 26101 Phone: (304) 485-5428 | |
Cvs Pharmacy # 06276 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1800 Broadway Ave, Parkersburg, West Virginia 26101 Phone: (304) 485-4533 | |
Cvs Pharmacy # 06281 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 4418 Emerson Avenue, Parkersburg, West Virginia 26104 Phone: (304) 485-3245 | |
Cvs Pharmacy #07604 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2323 Murdoch Ave, Parkersburg, West Virginia 26101 Phone: (304) 422-2884 |